Robotic surgery devices market seen topping $18 billion by 2030

The robotic surgery devices market is forecast to rise from $8.81 billion in 2025 to $10.19 billion in 2026, according to The Business Research Company. Growth is being driven by minimally invasive surgery demand, hospital investment and wider use of robotic and AI-assisted surgical tools.

Why it matters: - The robotic surgery devices market is expanding as hospitals and surgeons shift toward minimally invasive procedures that can reduce tissue damage and recovery time. - The market’s growth signals wider adoption of robotic systems in complex surgeries, with implications for operating room technology, training and patient outcomes.

What happened: - The Business Research Company published a report on the robotic surgery devices market covering 2026 through 2035. - The report forecasts the market will grow from $8.81 billion in 2025 to $10.19 billion in 2026. - The report projects the market will reach $18.08 billion by 2030. - North America held the largest share of the global robotic surgery devices market in 2025. - Western Europe ranked as the second-largest regional market. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - The market is projected to grow at a CAGR of 15.7% from 2025 to 2026. - The market is projected to grow at a CAGR of 15.4% from 2026 to 2030. - Growth drivers include rising demand for minimally invasive surgical techniques, surgeons’ preference for robotic assistance, hospital investment in advanced surgical systems, more complex procedures and ongoing improvements in robotic instruments. - Longer-term growth is expected to come from autonomous surgical features, greater demand for precision surgery, expansion of robotic surgery training programs, wider use of AI-assisted decision-making tools and more outpatient robotic surgeries. - Emerging trends include robot-assisted minimally invasive surgeries, multi-specialty robotic platforms, advanced surgical visualization, remote and teleoperated procedures and a stronger focus on surgical precision and patient outcomes. - The report describes robotic surgery devices as tools that let surgeons perform complex minimally invasive procedures with enhanced accuracy and flexibility. - The company says its 2026 market reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis and updated graphics and tables.

Between the lines: - The market outlook points to a shift from basic robotic assistance toward more autonomous, AI-enabled surgical workflows. - The regional ranking suggests North America remains the early revenue center for robotic surgery, while broader global adoption is still unfolding. - The emphasis on training and outpatient procedures suggests the market is expanding beyond flagship hospitals into more routine care settings. - The report cites a June 2024 American Society of Plastic Surgeons update showing minimally invasive procedures rose 7% in 2023, while traditional surgeries rose 2%. - That same update said hand surgeries for carpal tunnel syndrome, arthritis and trigger finger totaled 207,887, up 2% from 2022.

What's next: - The market is expected to keep expanding through 2030 as more hospitals adopt robotic platforms and manufacturers add AI, visualization and teleoperation capabilities. - Continued growth in minimally invasive procedures is likely to support additional spending on robotic surgery systems and surgeon training. - Broader regional adoption could follow as the technology moves into more specialties and outpatient settings.

The bottom line: - Robotic surgery devices are moving from a specialized toolset toward a larger, faster-growing category in medical technology, with AI and precision surgery likely to shape the next phase of growth.